The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

I had a high-flying job that involved a lot of stress and little sleep – until a cancer diagnosis made me turn my life around ...

Although not preferred for early-stage thyroid cancer, chemotherapy may be beneficial in advanced, aggressive cases. However, it comes with side-effects such as nausea, fatigue and hair loss ...

Despite multimodality treatment for thyroid cancer ... role at least as part of a multimodality approach for advanced thyroid cancer. Gene therapy for thyroid cancer represents a new technology ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...